iron sucrose (venofer) Report issue

Small molecule Experimental
AACT ChEMBL

Active Ingredient History

NOW
  • Now
Intravenous iron sucrose is a commonly used treatment for iron deficiency anemia. Iron sucrose replaces iron in the blood to foster red blood cell production in patients with chronic kidney disease. Iron sucrose has the trade name Venofer.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

Australia

$4.0424

United States

$12.0150 - $61.6320
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

trivalent saccharose hydroxide ferrous | venofer

Organizations (28)

Research & Development (27)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (11)

Approved Indications (1)


 

Anemia

Experimental Indications - Clinical Trial Phases 1-4 (11)


 

Acute Kidney Injury (Phase 2)

Altitude Sickness (Phase 4)

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Carcinoma, Ovarian Epithelial (Phase 1/Phase 2)

Drugs, Generic (Phase 1)

Heart Failure (Phase 4)

Hemodialysis, Home (Phase 3)

Inflammatory Bowel Diseases (Phase 4)

Iron Deficiencies (Phase 4)

Kidney Failure, Chronic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 25
  • # of Trial Organizations: 27

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue